Mckesson Corp (MCK): Wayne A Budd , director of Mckesson Corp sold 2,309 shares on Sep 12, 2016. The Insider selling transaction was reported by the company on Sep 13, 2016 to the Securities and Exchange Commission. The shares were sold at $179.70 per share for a total value of $414,920.16 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Sep 7, 2016, John H Hammergren (Chairman, President & CEO) sold 100,500 shares at $184.22 per share price.On Aug 23, 2016, M Christine Jacobs (director) sold 915 shares at $193.78 per share price.Also, On Aug 1, 2016, Marie L/ca Knowles (director) sold 915 shares at $192.73 per share price.On Jul 15, 2016, James A Beer (EVP & Chief Financial Officer) sold 5,500 shares at $199.00 per share price.
McKesson Corporation: On Monday, Sep 12, 2016 heightened volatility was witnessed in McKesson Corporation which led to swings in the share price. The shares opened for trading at $175.22 and hit $181.53 on the upside , eventually ending the session at $180.47, with a gain of 2.49% or 4.38 points. The heightened volatility saw the trading volume jump to 1,901,181 shares. The 52-week high of the share price is $208.03 and the company has a market cap of $40,732 M . The 52-week low of the share price is at $148.29.
Company has been under the radar of several Street Analysts.McKesson Corporation is Reiterated by Mizuho to Neutral and the brokerage firm has raised the Price Target to $ 197 from a previous price target of $174 .The Rating was issued on Aug 11, 2016.
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers and practice management technology clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical patient care financial supply chain and strategic management software solutions as well as connectivity outsourcing and other services including remote hosting and managed services to healthcare organizations.